NO20075409L - Substituerte aminoalkyl- og amidoalkyl-benzopyranderivater - Google Patents
Substituerte aminoalkyl- og amidoalkyl-benzopyranderivaterInfo
- Publication number
- NO20075409L NO20075409L NO20075409A NO20075409A NO20075409L NO 20075409 L NO20075409 L NO 20075409L NO 20075409 A NO20075409 A NO 20075409A NO 20075409 A NO20075409 A NO 20075409A NO 20075409 L NO20075409 L NO 20075409L
- Authority
- NO
- Norway
- Prior art keywords
- bicyclic
- mono
- straight
- amidoalkyl
- substituted aminoalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05006752 | 2005-03-29 | ||
| PCT/EP2006/001572 WO2006102958A1 (en) | 2005-03-29 | 2006-02-22 | Substituted aminoalkyl- and amidoalkyl-benzopyran derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20075409L true NO20075409L (no) | 2007-10-23 |
Family
ID=34934549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20075409A NO20075409L (no) | 2005-03-29 | 2007-10-23 | Substituerte aminoalkyl- og amidoalkyl-benzopyranderivater |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20090005436A1 (es) |
| EP (1) | EP1863784A1 (es) |
| JP (1) | JP2008535824A (es) |
| KR (1) | KR20070121028A (es) |
| CN (1) | CN101137638A (es) |
| AR (1) | AR053453A1 (es) |
| AU (1) | AU2006228787A1 (es) |
| BR (1) | BRPI0609265A2 (es) |
| CA (1) | CA2601126A1 (es) |
| IL (1) | IL184841A0 (es) |
| MX (1) | MX2007011832A (es) |
| NO (1) | NO20075409L (es) |
| NZ (1) | NZ560666A (es) |
| RU (1) | RU2392276C2 (es) |
| TW (1) | TW200716527A (es) |
| WO (1) | WO2006102958A1 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080194522A1 (en) * | 2004-08-25 | 2008-08-14 | Gong Chen | Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) |
| US8337941B2 (en) * | 2006-07-27 | 2012-12-25 | The Trustees Of Columbia University In The City Of New York | Fluorescent substrates for monoamine transporters as optical false neurotransmitters |
| JP2010536347A (ja) * | 2007-08-17 | 2010-12-02 | ユニヴァーシティ オブ ワシントン | α−イズロニダーゼ酵素活性の検定のための方法 |
| CA2788425A1 (en) * | 2010-01-29 | 2011-08-04 | Dalibor Sames | Ph-responsive fluorescent false neurotransmitters and their use |
| JP6180423B2 (ja) | 2011-11-08 | 2017-08-16 | ユニヴァーシティ オブ ワシントン | リソソーム酵素アッセイ法および組成物 |
| SG11201504704TA (en) | 2013-03-14 | 2015-07-30 | Dart Neuroscience Llc | Substituted naphthyridine and quinoline compounds as mao inhibitors |
| US10793509B2 (en) * | 2013-09-24 | 2020-10-06 | Universität Zu Koln | Compounds useful in the treatment of neoplastic diseases |
| RU2720510C2 (ru) * | 2017-07-04 | 2020-04-30 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" | Производные кумарина, тиокумарина и хинолинона, обладающие противосудорожной активностью |
| CN109761964B (zh) * | 2018-12-29 | 2021-02-02 | 浙江工业大学 | 香豆素骈3-羟基吡啶-4-酮的衍生物及其制备方法与应用 |
| CN115023222A (zh) * | 2019-10-25 | 2022-09-06 | J·夸克 | 神经系统病症的治疗 |
| CN110804045B (zh) * | 2019-11-08 | 2021-07-27 | 浙江工业大学 | 具潜在抗ad活性的香豆素杂合吡啶酮酰胺衍生物及其制备方法与应用 |
| CN111875555B (zh) * | 2020-08-11 | 2022-07-19 | 南京合创药业有限公司 | 一种糖精-6-乙酸酯的合成方法 |
| WO2022204150A1 (en) * | 2021-03-22 | 2022-09-29 | Blue Oak Pharmaceuticals, Inc. | Compounds and compositions for treating cns disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0325964A1 (en) * | 1988-01-15 | 1989-08-02 | Abbott Laboratories | Aminomethyl-chroman and -thiochroman compounds |
| DE3834860A1 (de) * | 1988-10-13 | 1990-04-19 | Basf Ag | Heterocyclisch substituierte alkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel |
| DE4337906A1 (de) * | 1993-11-08 | 1995-05-11 | Cassella Ag | Verwendung von Cumarinderivaten |
| IL127858A0 (en) * | 1996-07-01 | 1999-10-28 | Schering Corp | Muscarinic antagonists |
| AU2001288045A1 (en) * | 2000-09-14 | 2002-03-26 | Mitsubishi Pharma Corporation | Novel amide derivatives and medicinal use thereof ugs |
-
2006
- 2006-02-22 RU RU2007139700/04A patent/RU2392276C2/ru not_active IP Right Cessation
- 2006-02-22 BR BRPI0609265-9A patent/BRPI0609265A2/pt not_active IP Right Cessation
- 2006-02-22 NZ NZ560666A patent/NZ560666A/en unknown
- 2006-02-22 US US11/909,095 patent/US20090005436A1/en not_active Abandoned
- 2006-02-22 EP EP06723075A patent/EP1863784A1/en not_active Withdrawn
- 2006-02-22 CA CA002601126A patent/CA2601126A1/en not_active Abandoned
- 2006-02-22 AU AU2006228787A patent/AU2006228787A1/en not_active Abandoned
- 2006-02-22 WO PCT/EP2006/001572 patent/WO2006102958A1/en active Application Filing
- 2006-02-22 JP JP2008503383A patent/JP2008535824A/ja not_active Withdrawn
- 2006-02-22 CN CNA2006800080033A patent/CN101137638A/zh active Pending
- 2006-02-22 KR KR1020077024944A patent/KR20070121028A/ko not_active Application Discontinuation
- 2006-02-22 MX MX2007011832A patent/MX2007011832A/es not_active Application Discontinuation
- 2006-03-14 TW TW095108545A patent/TW200716527A/zh unknown
- 2006-03-27 AR ARP060101166A patent/AR053453A1/es unknown
-
2007
- 2007-07-26 IL IL184841A patent/IL184841A0/en unknown
- 2007-10-23 NO NO20075409A patent/NO20075409L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ560666A (en) | 2010-01-29 |
| AU2006228787A1 (en) | 2006-10-05 |
| AR053453A1 (es) | 2007-05-09 |
| US20090005436A1 (en) | 2009-01-01 |
| CN101137638A (zh) | 2008-03-05 |
| CA2601126A1 (en) | 2006-10-05 |
| RU2007139700A (ru) | 2009-05-10 |
| JP2008535824A (ja) | 2008-09-04 |
| WO2006102958A1 (en) | 2006-10-05 |
| EP1863784A1 (en) | 2007-12-12 |
| IL184841A0 (en) | 2007-12-03 |
| TW200716527A (en) | 2007-05-01 |
| KR20070121028A (ko) | 2007-12-26 |
| MX2007011832A (es) | 2007-11-22 |
| BRPI0609265A2 (pt) | 2010-03-09 |
| RU2392276C2 (ru) | 2010-06-20 |
| AU2006228787A2 (en) | 2006-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20075409L (no) | Substituerte aminoalkyl- og amidoalkyl-benzopyranderivater | |
| TW200833675A (en) | Nicotinamide derivatives | |
| NO20076196L (no) | Nye 2-azetidinonderivater som kolesterolabsorpsjonsinhibitorer for behandling av hyperlipidemiske tilstander | |
| NO20076197L (no) | Nye 2-azetidinonderivater anvendbare i behandling av hyperlipidemiske tilstander | |
| NO20085060L (no) | Triazolpyrazinderivater anvendelige som anti-cancermidler | |
| NO20076254L (no) | Nye 2-azetidinonderivater som kolesterolabsorpsjonsinhibitorer for behandling av hyperlipidemiske tilstander | |
| NO20066055L (no) | Pyridinderivater | |
| NO20076195L (no) | Nye 2-azetidinonderivater for behandling av hyperlipidemiske sykdommer | |
| NO20072978L (no) | Nye betuinderivater, preparat derav og anvendelse derav | |
| NO20076137L (no) | Nye 2-azetidinonderivater og deres anvendelse som kolestrolabsorpsjonsinhibitorer for behandling av hyperlipidemi | |
| NO20083434L (no) | Benzamid- og heteroarenderivater | |
| NO20091889L (no) | Inhibitorer av spiroketon acetyl-CoA karboksylase | |
| WO2008012635A3 (en) | Amine derivatives useful as anticancer agents | |
| NO20080865L (no) | Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer | |
| MY144588A (en) | Novel coumarin derivative having antitumor activity | |
| NO20076138L (no) | Nye 2-azetidinonderivater som kolesterolabsorpsjonsinhibitorer for behandling av hyperlipidemiske tilstander | |
| NO20082496L (no) | Pyrazinderivater | |
| NO20085385L (no) | Tiazolforbindelser som cannabinoidreseptorligander og anvendelser derav | |
| NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
| NO20092033L (no) | Nye forbindelser | |
| NO20073791L (no) | Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer | |
| NO20082445L (no) | Neuropeptid-2 reseptor-agonister | |
| NO20092286L (no) | Nitrogenhaldige heterosykliske forbindelser og anvendelse derav | |
| NO20072409L (no) | Substituerte n-sulfonylaminobenzyl-2-fenoksy acetamid-forbindelser | |
| NO20054135L (no) | Kipolinon/benzoksazin derivater og anvendelser derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |